Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.
Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.
NPJ Genomic Medicine|April 10, 2026
Clinical validation of a high-performance somatic exome sequencing assay: from target-enrichment strategy to variant callingJunko Tsuji, Micah Rickles-Young, Justin Abreu, et al.
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Blood Advances|July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationMax Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Nature Medicine|June 15, 2023
Clonal hematopoiesis is associated with protection from Alzheimer's diseaseHind Bouzid, Julia A Belk, Max Jan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Nature Genetics|April 21, 2015
COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritisLevi B Watkin, Birthe Jessen, Wojciech Wiszniewski, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 3